What is the ticker symbol for Artiva Biotherapeutics?

Artiva Biotherapeutics trades under the ticker ARTV on NASDAQ.

What sector does Artiva Biotherapeutics operate in?

Artiva Biotherapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ARTV in a portfolio?

PortView shows ARTV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Artiva Biotherapeutics (ARTV) Stock Analysis

NASDAQHealthcareBiotechnology

$11.32+0.34%

1-year price historyRange $2.28 – $13.39

52-week range$11.32

$2.22$14.53

What Artiva Biotherapeutics does

Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology firm specializing in the development of natural killer (NK) cell-based treatments for individuals afflicted with autoimmune disorders and various forms of cancer. Its flagship therapeutic candidate, AB-101, is an innovative, ready-to-use (off-the-shelf) NK cell therapy. This treatment is being developed for a broad spectrum of conditions, including autoimmune diseases like lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, systemic lupus erythematosus, and specific anti-neutrophil cytoplasmic antibody-associated vasculitis subtypes such as granulomatosis with polyangiitis/microscopic polyangiitis, in addition to B-cell non-Hodgkin lymphoma. The company's pipeline also includes AB-201, an allogeneic anti-human epidermal growth factor receptor 2 chimeric antigen receptor (CAR)-NK cell candidate, and AB-205, another allogeneic anti-CD5 CAR-NK cell candidate. Established in 2019, Artiva Biotherapeutics is headquartered in San Diego, California.

Key metrics

Market cap

$553.37M

P/E (TTM)

-3.43

EPS (TTM)

$-3.30

Beta

2.18

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$10.45

200-day avg

$7.29

52-week high

$14.53

52-week low

$2.22

CEO

Fred Aslan

ETFs linked to ARTV

Broad-market and Healthcare sector ETFs an investor holding Artiva Biotherapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ARTV fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ARTV in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Artiva Biotherapeutics?: Artiva Biotherapeutics trades under the ticker ARTV on NASDAQ.
Which exchange is ARTV listed on?: ARTV is listed on NASDAQ.
What sector does Artiva Biotherapeutics operate in?: Artiva Biotherapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ARTV in a portfolio?: PortView shows ARTV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.